Antibody Scientist - BD/Platform Licensing

Green Life Science; Boston (MA); On-site; USD 120,000 - 190,000; Full time

Job summary

Green Life Science in Boston is seeking an Antibody Discovery Scientist transitioning into a commercial role focused on out-licensing cutting-edge platforms for a global CRO/Biotech. The role is onsite in Boston with local travel up to 25%.

No prior experience is required as training is provided, but candidates should be able to communicate complex science to multiple stakeholders and have a strong understanding of early discovery workflows.

Qualifications

• Ph.D. in Pharmacology, Immunology, Cancer Biology or a related biomedical science discipline.
• Strong background in antibody drug discovery, with knowledge of target validation and hit-to-lead optimisation.
• Ability to interpret complex biological data and translate findings into therapeutic narratives.
• Strong understanding of antibody modalities (mAbs, bispecifics, ADCs).
• Excellent strategic and commercial thinking with cross-functional collaboration.
• Strong communication and stakeholder-management skills across scientific and executive audiences.

Responsibilities

• Identify and develop external business opportunities across out-licensing, co-development and other strategic transactions.
• Lead development and presentation of business cases for opportunities.
• Independently initiate, develop and present external opportunities to senior management.
• Lead cross-functional due diligence and alliance management with R&D, CMC, Clinical, Regulatory, Operations and Finance.
• Manage BD activities through the transaction lifecycle including proposals, term sheets, negotiations and alliance management.
• Contribute to BD strategy aligned with corporate and portfolio objectives.
• Represent organisation at industry, investor and partnering conferences.

Skills

Antibody discovery

Stakeholder management

Strategic thinking

Education

PhD in biomedical sciences

Job description

A unique opportunity for Antibody Discovery Scientists to transition into a commercial role focusing on out licensing cutting edge platforms on behalf of a global CRO/Biotech based in Boston.

Please note the role will be onsite in Boston with local travel 25%

No previous experience is required as training is provided but most show ability to communicate complex science to multiple stakeholders and strong understanding of early discovery workflows!

The Role

• Identify and develop external business opportunities across out-licensing, co-development and other strategic transactions.


• Lead the development and presentation of compelling business cases for prioritized external opportunities, providing robust analysis of key assumptions, risks and internal/external considerations.


• Independently initiate, develop and present external opportunities to senior management.


• Lead cross-functional due diligence and alliance management, working closely with R&D, CMC, Clinical, Regulatory, Operations and Finance teams, while providing executive-level reporting and acting as the primary BD contact where required.


• Manage BD activities throughout the transaction lifecycle, including proposals, term sheet development, negotiations, deal execution and ongoing alliance management.


• Contribute to the development and evolution of the organisation's business development and licensing strategy, ensuring alignment with broader corporate and portfolio objectives.


• Represent the organisation at industry, investor and partnering conferences, building and maintaining relationships across the pharmaceutical and biotechnology sectors.

Requirements

• Ph.D. in Pharmacology, Immunology, Cancer Biology or a related biomedical science discipline.


• Strong background in antibody drug discovery, with a deep understanding of target validation and hit-to-lead optimisation.


• Ability to interpret complex biological data, including affinity, specificity and in vivo efficacy, and translate scientific findings into compelling therapeutic and licensing narratives.


• Strong understanding of modern antibody modalities, including monoclonal antibodies, bispecific antibodies and ADCs.


• Excellent strategic and commercial thinking, with the ability to connect internal scientific capabilities with pharmaceutical and biotechnology partner needs.


• Strong communication, presentation and stakeholder-management skills, with the ability to work effectively across scientific, commercial and executive audiences.